Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
David Elsbree Insider Profile
4 Followers
David Elsbree, Director at T2 Biosystems, holds 25.00 shares in T2 Biosystems (Ticker: TTOO), holds 0.00 shares in Acme Packet (Ticker: APKT). Most recently, David Elsbree Sold ― shares of T2 Biosystems on Sep 17, 2024 for an estimated value of 133.10.
Profitable Transactions
4 out of 11 Profitable Transactions
Average Return
-3.60%
Average return per transaction
Time Frame
Compare to
Insider Roles
Director
Roles that David Elsbree holds in companies
Most Profitable Insider Trade
The most profitable trade made by David Elsbree
David Elsbree's Trading History
T2 Biosystems
Sep 17, 2024
Director
Informative Sell
133.10
$8.75
Acme Packet
―
―
―
―
List of latest transactions for each holding click on a transaction to see David Elsbree's performance on stock
You May Also Like
David Elsbree insider profile FAQ
What is the percentage of profitable transactions made by David Elsbree?
The percentage of profitable transactions made by David Elsbree is 36%.
What is the average return per transaction made by David Elsbree?
The average return per transaction made by David Elsbree is -3.60%.
What stocks does David Elsbree hold?
David Elsbree holds: TTOO, APKT stocks.
What was David Elsbree’s latest transaction?
David Elsbree latest transaction was an Informative Sell of $133.10.
What was David Elsbree's most profitable transaction?
David Elsbree’s most profitable transaction was an Informative Buy of TTOO stock on June 8, 2017. The return on the trade was 174.60%.
What is David Elsbree's role in T2 Biosystems?
David Elsbree's role in T2 Biosystems is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.